Home > Insider Trading > Filing (0001209191-21-060910)

Filing Details

Accession Number:: 0001209191-21-060910
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-10-19 16:28:15
Reporting Period:: 2021-10-18

Accepted Time:: 2021-10-19 16:28:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1810182	Alx Oncology Holdings Inc	ALXO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1188956	S Peter Garcia	C/O Alx Oncology Holdings Inc. 866 Malcolm Road, Suite 100 Burlingame CA 94010	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-10-18	7,229	$4.08	16,560	No	4	M	Direct
Common Stock	Disposition	2021-10-18	2,851	$54.33	13,709	No	4	S	Direct
Common Stock	Disposition	2021-10-18	1,903	$55.15	11,806	No	4	S	Direct
Common Stock	Disposition	2021-10-18	1,437	$56.09	10,369	No	4	S	Direct
Common Stock	Disposition	2021-10-18	411	$57.54	9,958	No	4	S	Direct
Common Stock	Disposition	2021-10-18	438	$58.30	9,520	No	4	S	Direct
Common Stock	Disposition	2021-10-18	189	$59.06	9,331	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2021-10-18	7,229	$0.00	7,229	$4.08

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,468		2030-03-09	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Employee Stock Option (right to buy)	$4.08		2030-03-09	95,659	95,659	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2030-03-09	95,659	95,659	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.73 to $54.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (7) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.73 to $55.70, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.73 to $56.62, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.86 to $57.845, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.86 to $58.85, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.96 to $59.23, inclusive.
The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vest on March 9, 2021 and 1/36th of the remaining shares vest monthly thereafter.
The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 2, 2021 and 1/36th of the remaining shares vest monthly thereafter.